Genital Chlamydia trachomatis: An update

Indian Journal of Medical Research

Volumn 138, Issue SEP, 2013, Pages 303-316

  Malhotra, Meenakshi ^b   Sood, Seema ^a   Mukherjee, Anjan ^a   Muralidhar, Sumathi ^b   Bala, Manju ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

Chlamydia trachomatis; Epidemiology; Genetics; Immunology; Treatment

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BACTERIAL VACCINE; CEFOXITIN; CEFTRIAXONE; CHAPERONIN 60; DOXYCYCLINE; ERYTHROMYCIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREPAFLOXACIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN; PROBENECID; SPARFLOXACIN; SULFONAMIDE; TOSUFLOXACIN; TROVAFLOXACIN; TUMOR NECROSIS FACTOR ALPHA; CHLAMYDIA TRACHOMATIS VACCINE; CLINDAMYCIN; IMMUNOGLOBULIN G ANTIBODY; ISOLEUCINE; LIPOPOLYSACCHARIDE; MAJOR OUTER MEMBRANE PROTEIN; ORAL CONTRACEPTIVE AGENT; OUTER MEMBRANE PROTEIN; RNA 16S; RNA 23S; TETRACYCLINE; TRANSFORMING GROWTH FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CYTOLOGY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENITAL TRACT INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INFERTILITY; MIXED INFECTION; MOLECULAR DIAGNOSIS; NONHUMAN; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PRIMARY INFECTION; QUALITY CONTROL; REVIEW; RISK FACTOR; SEROLOGY; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CARCINOMA; 16S RRNA GENE; 23S RRNA GENE; ABDOMINAL PAIN; AGE; CELL CULTURE; CLINICAL PRACTICE; CONJUNCTIVITIS; CYTOKINE RELEASE; DIAGNOSTIC TEST ACCURACY STUDY; DIET; DIFFERENTIAL DIAGNOSIS; DIRECT FLUORESCENT TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA PROBE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPAREUNIA; DYSURIA; ENZYME ASSAY; EPIDIDYMITIS; FALSE NEGATIVE RESULT; FEVER; GONORRHEA; HEALTH PROGRAM; HETEROTYPIC RESISTANCE; IN VITRO STUDY; INCIDENCE; INFECTION; INFECTION CONTROL; INFECTION RISK; LABORATORY TEST; LEUKOCYTE ESTERASE TEST; LIFESTYLE MODIFICATION; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MOMP GENE; MULTIDRUG RESISTANCE; NEISSERIA GONORRHOEAE; NEUTROPHIL; NUCLEIC ACID AMPLIFICATION; ORCHITIS; PATIENT COMPLIANCE; PHOSPHOLIPASE GENE; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREMATURE FETUS MEMBRANE RUPTURE; PREVALENCE; PROPHYLAXIS; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; REHABILITATION; REITER SYNDROME; RESPIRATORY TRACT INFECTION; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL COUNSELING; SEXUAL EDUCATION; SEXUAL PRACTICE; SOCIOECONOMICS; TH1 CELL; TREATMENT DURATION; TREATMENT INDICATION; UNCOMPLICATED INFECTION; URETHRITIS; URINALYSIS; UROGENITAL TRACT INFECTION; UTERINE CERVICITIS; VACCINATION;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES;

EID: 84885034382     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Global prevalence and incidence of selected curable sexually transmitted diseases: Overview and estimates. Geneva: World Health Organization; 2011.
2. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update 1999; 5: 433-47.
3. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: Incidence and prevalence estimate, 2000. Perspect Sex Reprod Health 2004; 36: 6-10.
4. Sexually transmitted disease surveillance 2003 supplement. Division of STD Prevention 2004, Deapartment of Health and Human Services, CDC, Atlanta.
5. Svenssòn LO, Mares I, Olsson SE, Norstorm ML. Screening for infection in women and aspects of the laboratory diagnostics. Acta Obstet Gynecol Scand 1991; 70: 587-590.
6. Soper DE. Pelvic inflammatory disease. Obstet Gynecol 2010; 116: 419-28.
7. Patel LA, Sachdev D, Nagpal P, Chaudary U, Sonkar AS, Mendiratta LS, et al. Prevalence of Chlamydial infection among women visiting a gynaecology outpatient department: evaluation of an in-house PCR assay for detection of Chlamydia trachomatis. Ann Clin Microbiol Antimicrob 2010; 9: 24-33.
8. Malhotra M, Bala M, Muralidhar S, Khunger N, Puri P. Prevalence of sexually transmitted infections in patients attending a tertiary care hospital in North India -a retrospective Study. Indian J Sex Transm Dis 2008; 29: 82-5.
9. Mittal A. Genital chlamydiasis. ICMR Bull 1992; 22: 103-6.
10. Vidhani S, Mehta S, Bhalla P, Bhalla R, Sharma VK, Batra S. Seroprevalence of Chalmydia trachomatis infection amongst patients with pelvic inflammatory diseases and infertility. J Commun Dis 2005; 37: 233-8.
11. Hills S, Black CM, Newhall J, Walsh C, Groseclose SL. New opportunities for chlamydia prevention: applications of Science to public health Practice. Sex Transm Dis 1995; 22: 197-202.
12. Miller EK. Diagnosis and treatment of Chlamydia trachomatis infection. Am Fam Physician 2006; 73: 1411-6.
13. Sexually transmitted diseases treatment guidelines 2010: Centers for Disease Control and Prevention, Atlanta, USA; 2010.
14. Stamm WE. Chlamydia trachomatis: progress and problems. J Infect Dis 1999; 179: S380-3.
15. Fleming DT, Wasserheit JN. From epidemiological synergy to Public health policy and Practice: the contribution of sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3-17.
16. th ed. New York: Oxford University Press Inc. 1999. p. 1331-6.
17. Rank RG, Ramsay KH, Pack EA. Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect Immun 1992; 60: 4427-9.
18. Malinverni R. The role of cytokines in chlamydial infections. Curr Opin Infect Dis 1996; 9: 150-5.
19. Morton RS, Kinghorn GR. Genitourinary chlamydial infection: a reappraisal and hypothesis. Int J STD AIDS 1999; 10: 765-75.
20. Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang Y, Anderson DJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydial infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 1997; 99: 77-87.
21. Witkin SS, Giraldo P, Linhares I, Ledgar WJ. Individual immunity and susceptility to female genital tract infection. Am J Obstect Gynecol 2000; 183: 252-6.
22. Morrison SG, Morrison RP. A predominant role of antibody in acquired immunity to chlamydial genital tract reinfection. J Immunol 2005; 73: 6183-6.
23. Paavonen J. Immunopathogenesis of pelvic inflammatory disease and infertility what do we know what shall we do? J Br Fert S 1996; 1: 42-5.
24. Domeika M, Mardh PA. ABC on Chlamydia. Syva, a Syntex Company, Berkshire; 1993.
25. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010; 201 (Suppl 2): S134-55.
26. Zdrodowska-Stefanow B, Ostaszewska-Puchalska I, Pucilo K. The immunology of Chlamydia trachomatis Arch Immunol Ther Exp 2003; 51: 289-94.
27. Burstein GR, Gaydos CA, Diener-West M. Incident Chlamydia trachomatis infection among inner-city adolescents. JAMA 1998; 280: 521-6.
28. Novak M, Novak D. Risk factors for Chlamydia trachomatis infection among users of an internet-based testing service in Sweeden. Sex Reprod Health 2013; 4: 23-7.
29. th ed. Mandell GL, Bennett JE, Dolin R, editors. Philadelphia: Churchill Livingstone Elsevier; 2010.
30. Divekar AA, Gogate AS, Shivkar LK, Gogate S, Badhwar VP. Disease prevalence in women attending the STD clinic in Mumbai (formerly Bombay), India. Int J STD AIDS 2000; 11: 45-8.
31. Malik A, Jain S, Hakim S, Shukla I, Rizvi M. Chlamydia trachomatis infection and infertility. Indian J Med Res 2006; 123: 770-5.
32. Ray K, Yadav S. Prevalence of C.trachomatis and other sexually transmitted pathogens in female reproductive tract infections. Indian J Med Microbiol 1997; 15: 1-4.
33. Sharma K, Aggarwal A, Arora U. Seroprevalence of Chlamydia trachomatis in women with bad obstretic history and infertility. Indian J Med Sci 2002; 56: 216-7.
34. Joyee AG, Thyagarajan SP, Sowmya B, Venkatesan C, Ganapathy M. Need for specific and routine strategy for the diagnosis of genital chlamydial infection among patients with sexually transmitted disease in India. Indian J Med Res 2003; 118: 152-7.
35. Anand Kumar BH, Vijay D, Premalatha KG, Ravi R. Coinfection of Neisseria gonorrhoeae and Chlamydia trachomatis in urethritis. Indian J Sex Trans Dis 2001; 22: 24-6.
36. Adams EJ, Charlett A, Edmunds WJ, Hughes G. Chlamydia trachomatis in the United Kingdom; review and analysis of prevalence studies. Sex Transm Infect 2004; 80: 354-62.
37. Vuylsteke B, Vandenbruaene M, VanDyck E, Laga M. Chlamydia trachomatis Prevalence and sexual behaviour among female adolescent in Belgium. Sex Transm Infect 1999; 75: 152-5.
38. Renton A, Thomas BM, Gill S, Lowndes C, Robinson DT, Peterson K. Chlamydia trachomatis in cervical and vaginal swabs and Urine specimens from women undergoing termination of pregnancy. Int J STD AIDS 2006; 17: 443-7.
39. Gunn RA, Hillis SD, Shirey P, Waterman SH, Greenspan JR. Chlamydia trachomatis infection among Hispanic women in the California-Mexico border area 1993: establishing screening in a primary care setting. Sex Transm Dis 1995; 22: 329-34.
40. Oliveira FA, Pfleger V, Lang K, Heukelbach J, Miralles I, Fraga F, et al. Sexually transmitted infections, Bacterial vaginosis and candidiasis in women of reproductive age in rural Northeast Brazil: a population based study. Mem inst Oswaldo Cruz 2007; 102: 751-6.
41. Behets FM, Ward E, Fox L, Reed R, Spuryt A, Bennett L, et al. Sexually transmitted diseases are common in women attending Jamaican family planning clinics and appropriate detection tools are lacking. Sex Transm Infect 1998; 74 (Suppl 1): S123-S7.
42. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infection. Clin Microbiol Rev 1997; 10: 160-84.
43. Thejls H, J.Gnarpe, Gnarpe H. Expanded gold standard in the diagnosis of Chlamydia trachomatis in a low prevalence population: diagnostic efficacy of tissue culture, direct immunofluorescence, enzyme immunoassay, PCR and serology. Genitourin Med 1994; 70: 300-3.
44. Jalgaonkar SV, Pathak AA, Thakur YS. Enzyme immunoassay for rapid detection of Chlamydia trachomatis in urogenital infections. Indian J Sex Trans Dis 1990; 1: 23-6.
45. Mukherjee A, Sood S, Bala M, Satpathy G, Mahajan N, Kapil A, et al. The role of a commercial enzyme immuno assay antigen detection system for diagnosis of C. trachomatis in genital swab samples. Indian J Med Microbiol 2011; 29: 411-3.
46. Thomas B, MacLeod E, Hay P, Horner P, Taylor-Robinson D. Limited value of two widely used enzyme immunoassays for detection of Chlamydia trachomatis in women. Eur J Clin Microbiol Infect Dis 1994; 13: 651-5.
47. Clarke L, Sierra M, Diadone B, Lopez N, Covino J, McCormack W. Comparison of the Syva Microtrak enzyme immunoassay and Gen-Probe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population. J Clin Microbiol 1993; 31: 968-71.
48. Altwegg M, Burger D, Lauper U, Schär G. Comparison of Gen-Probe PACE 2, Amplicor Roche, and a conventional PCR for the detection of Chlamydia trachomatis in genital specimens. Med Microbiol Lett 1994; 3: 181-7.
49. Mahony JB, Luinstra KE, Sellors JW, Chernesky MA. Comparison of plasmid-and chromosome-based polymerase chain reaction assays for detecting Chlamydia trachomatis nucleic acids. J Clin Microbiol 1993; 31: 1753-8.
50. Schachter J, Hook WE, Martin DH, Willis W, Fine P, Fuller D, et al. Confirming positive results of Nucleic Acid amplification tests (NAATs) for Chlamydia trachomatis: All NAATs are not created equal. J Clin Microbiol 2005; 43: 1372-3.
51. Ossewaarde JM, Rieffe M, Rozenberg-Arska M, Ossenkoppele PM, Nawrocki RP, van Loon AM. Development and clinical evaluation of a polymerase chain reaction test for detection of Chlamydia trachomatis. J Clin Microbiol 1992; 30: 2122-8.
52. Michel CE, Sonnex C, Carne CA, White JA, Magbanua JP, Nadala EC, et al. Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies. J Clin Microbiol 2007; 45: 1395-402.
53. Geisler WM, Suchland RJ, Whittington WL, Stamm WE. Quantitative culture of Chlamydia trachomatis: relationship of inclusion forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease. J Infect Dis 2001; 184: 1350-4.
54. Black CM, Marrazzo J, Johnson RE, Hook EW, Jones RB, Green TA, et al. Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard. J Clin Microbiol 2002; 40: 3757-63.
55. Gaydos CA, Theodore M, Dalesio N, Wood BJ, Quinn TC. Comparison of three nucleic acid amplification tests for Chlamydia trachomatis in urine specimens. J Clin Microbiol 2004; 42: 3041-5.
56. Schachter J. NAATs to diagnose Chlamydia trachomatis genital infection: a promise still unfulfilled. Exp Rev Mol Diagn 2001; 1: 137.
57. Gronowski AM, Copper S, Baorto D, Murray PR. Reproducibility problems with the Abbott Laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2000; 38: 2416-8.
58. Culler EE, Caliendo AM, Nolte FS. Reproducibility of positive test results in the BD probe Tec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2003; 41: 3911-4.
59. Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, et al. Screening test to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections. Centers for Disease Control and Prevention. MMWR 2002; 51: 1-22.
60. Ingram DL, Runyan DK, Collins AD. Vaginal Chlamydia trachomatis infection in the children with sexual contact. Pediatr Infect Dis 1984; 3: 97-9.
61. Saison F, Mahilum-Tapey L, C.E.Michel, Buttress ND, Nadala B, Magbanua JP, et al. Prevalence of Chlamydia trachomatis infection and performance of Chlamydia rapid tests among low-and high-risk Filipino women in resource-limited settings. J Clin Microbiol 2007; 45: 4011-7.
62. Jennifer B, Fabrice M. Chlamydia trachomatis: discovery of a new strain. J New Zeal Med Assoc 2007; 120: 86-7.
63. Price MJ, Ades AE, Angelis DD, Welton NJ, Macleod J, Soldan K, et al. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: Analysis of prospective studies with a multistate model. Am J Epidemiol 2013; 178: 484-92.
64. Ray K. Chlamydia trachomatis and infertility. Indian J Med Res 2006; 123: 730-4.
65. Cunningham KA, Beagly KW. Male genital tract chlamydial infection: Implications for pathology and infertility. Biol Reprod 2008; 79: 180-9.
66. Bala M, Mullick JB, Muralidhar S, Kumar J, Ramesh V. Gonorrhoea & its co-infection with other ulcerative, non- ulcerative sexually transmitted & HIV infection in a Regional STD Centre. Indian J Med Res 2011; 133: 346-9.
67. Tapsall JW, Kinchington M. The frequency of co-infection with Neisseria gonorrhoeae and Chlamydia trachomatis in men and women in eastern Sydney. Pathology 1996; 28: 84-7.
68. Divekar A, Gogate AS, Shivkar LK, Gogate S, Badhwar VR. Disease prevalence in women attending the STD clinic Disease prevalence in women attending the STD clinic in Mumbai (formerly Bombay). Int J STD AIDS 2000; 11: 45-8
69. Donati M, DiFrancesco A, D'Antuono A, Pignanelli S, Shurdhi A, Moroni A, et al. Chlamydia trachomatis serovar distribution and other concurrent sexually transmitted infections in heterosexual men with urethritis in Italy. Eur J Clin Microbiol Infect Dis 2009; 28: 523-6.
70. Lyss SB, Kamb ML, Peterman TA, J.S. Moran, Newman DR, Bolan G, et al. Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. Ann Intern Med 2003; 139: 178-85.
71. Nelson HD, Helfand M. Screening for Chlamydial infection. Am J Prev Med 2001; 20 (Suppl 3): 95-107.
72. Horner P. The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection. Sex Trans Infect 2006; 82: 340-3.
73. Mourad A, Sweet RL, Sugg N, Schachter J. Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother 1980; 18: 696-8
74. Jones RB, DerPol BV, Johnson RB. Susceptibility of Chlamydia trachomatis to trovafloxacin. J Antimicrob Chemother 1997; 39 (Suppl B): 63-5.
75. Lefevre JC, Lepargneur JP, Guion D, Bei S. Tetracycline resistant Chlamydia trachomatis in Toulouse, France. Pathologie Biologie (Paris) 1997; 45: 376-8.
76. Somani J, Bhullar VB, Workowski KA, Farshy CE, Black CM. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000; 181: 1421-7.
77. Schachter J, Cles L, Ray R, Hesse FE. Is there immunity to chlamydial infections of the human genital tract? Sex Transm Dis 1983; 10: 123-5.
78. Miyashita N, Niki Y, Kishimoto T, Nakajima M, Matsushima T. In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia sp. Antimicrob Agents Chemother 1997; 41: 1331-4.
79. Gray RT, Beagley KW, Timms P, Wilson DP. Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection. J Infect Dis 2009; 199: 1680-8.
80. Mestecky J, Moldoveanu Z, Russell MW. Immunologic uniqueness of the genital tract: challenge for vaccine development. Am J Reprod Immunol 2005; 53: 208-14.